AAAAAA
Results: 26-33/33
Authors:
GORE SD
WENG LJ
BURKE PJ
Citation: Sd. Gore et al., BIOLOGIC AND CLINICAL IMPACT OF GROWTH-FACTOR (GF) AUGMENTATION OF POSTREMISSION CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000582-10000582
Authors:
WENG LJ
SAMID D
BURKE PJ
GORE SD
Citation: Lj. Weng et al., IRREVERSIBLE INHIBITION OF PROLIFERATION OF PRIMARY ACUTE MYELOID LEUKEMIC (AML) CELLS BY PHENYL BUTYRATE (PB), Blood, 84(10), 1994, pp. 10000628-10000628
Authors:
BURKE PJ
GORE SD
Citation: Pj. Burke et Sd. Gore, INTERLEUKIN-3 COMBINED WITH TIMED SEQUENTIAL THERAPY IN POOR SICK ACUTE MYELOCYTIC-LEUKEMIA, Experimental hematology, 21(8), 1993, pp. 1033-1033
Authors:
JONES RJ
BEDI A
MILLER CB
KAUFMANN SH
ZICHA MS
BARBER JP
BURKE PJ
GORE SD
Citation: Rj. Jones et al., INHIBITION OF APOPTOSIS - A NOVEL MECHANISM OF RESISTANCE TO MULTIPLECYTOTOXIC AGENTS IN ACUTE MYELOID-LEUKEMIA, Experimental hematology, 21(8), 1993, pp. 1078-1078
Authors:
MILLER CB
DAVIS JL
NOGA S
GORE SD
JONES RJ
Citation: Cb. Miller et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HIGH-RISK ACUTE LYMPHOCYTIC-LEUKEMIA USING A 3-DRUG PURGING REGIMEN, Experimental hematology, 21(8), 1993, pp. 1107-1107
Authors:
GORE SD
WENG LJ
BURKE PJ
Citation: Sd. Gore et al., VALIDATION OF FLOW-CYTOMETRIC DETERMINATION OF KI67 EXPRESSION AS A MEASURE OF GROWTH-FACTOR RESPONSE IN ACUTE MYELOGENOUS LEUKEMIA, Experimental hematology, 21(13), 1993, pp. 1702-1708
Authors:
GORE SD
KARP JE
MILLER CB
BRAINE HL
HUMPHREY RL
KAUFMANN S
TUCKER RA
BURKE PJ
Citation: Sd. Gore et al., BRIEF INTENSIVE THERAPY FOR ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - SUPERIORITY OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 82(10), 1993, pp. 10000056-10000056
Authors:
GORE SD
JONES RJ
WENG LJ
COWAN K
JOHNSON MC
ZILCHA M
BURKE PJ
Citation: Sd. Gore et al., IN-VIVO ADMINISTRATION OF INTERLEUKIN-3 (IL-3) DURING REMISSION INDUCTION THERAPY FOR AML - PLEIOTROPIC EFFECTS ON DRUG-SENSITIVITY, Blood, 82(10), 1993, pp. 10000443-10000443